Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma

被引:2
|
作者
Jiang, Jie [1 ]
Liu, Bin [2 ]
Liu, Ruilin [3 ]
Yang, Wenzhuo [1 ]
机构
[1] Tongji Univ, Shanghai Tongji Hosp, Dept Gastroenterol & Hepatol, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
[2] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China
[3] Tongji Univ, Shanghai Tongji Hosp, Dept Pulm, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2021年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; TASP1; prognosis; biological functional networks; CANCER-CELL PROLIFERATION; GENE-EXPRESSION; WEB SERVER; TUMOR; BREAST; NETWORKS; INVASION; PROTEASE; PROTEOLYSIS; ENVIRONMENT;
D O I
10.2147/CMAR.S296069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Taspase 1 (TASP1) is a highly conserved protease involved in site-specific proteolysis. Existing researches have revealed a link between TASP1 expression and carcinogenesis. However, limited data are available regarding the prognosis and functions of TASP1 in hepatocellular carcinoma (HCC). Methods: Western Blotting and qRT-PCR were employed to evaluate the level of TASP1 in HCC cell lines and clinical specimens. TASP1 expression was further calculated in clinical specimens by immunohistochemistry and the mRNA level of TASP1 in HCC was analyzed using Oncomine and UALCAN databases. The TASP1 promoter methylation modification was shown via MEXPRESS and UALCAN. The association between TASP1 expression and postoperative prognosis was evaluated using Kaplan-Meier and Cox regression analysis in clinical patients. The effect of TASP1 on HCC prognosis was analyzed via Kaplan-Meier plotter, GEPIA and UALCAN. Additionally, the regulators, kinases, miRNA and transcription factor targets of TASP1 were identified using LinkedOmics. Moreover, cBioPortal was used to detect the genetic alteration of TASP1. Finally, TIMER was utilized to assess the relation between TASP1 and the immune cell infiltration, whereas the correlation of TASP1 with three immune factors was detected through TISIDB. Results: TASP1 expression was increased in HCC cell lines and HCC tissues. CNV and DNA methylation of TASP1 were changed. Survival analysis revealed that high TASP1 expression was correlated with overall survival (OS). Functional network analysis about TASP1 in HCC showed that the double-strand break repair, peptidyl-threonine modification, spindle organization, peptidyl-lysine modification and microtubule-based movement were modulated. Furthermore, TASP1 expression revealed puissant relation to the infiltration of immune cells and three immune factors in HCC. Conclusion: These data indicate that TASP1 may act as a potential prognostic marker in HCC and regulate HCC via multiple mechanisms.
引用
收藏
页码:2517 / 2537
页数:21
相关论文
共 50 条
  • [1] FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
    Wang, Yan
    Sun, Mengjing
    Liu, Jibin
    Liu, Ying
    Jiang, Chunyi
    Zhu, Huijun
    Wang, Wei
    Wang, Yao
    ONCOLOGY LETTERS, 2020, 19 (01) : 795 - 804
  • [2] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [3] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    Medical Oncology, 2013, 30
  • [4] Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Han, C-P
    Yu, Y-H
    Wang, A-G
    Tian, Y.
    Zhang, H-T
    Zheng, Z-M
    Liu, Y-S
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (17) : 5481 - 5489
  • [5] Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma
    Kong, Jienan
    Zhou, Xianchun
    Liu, Shusen
    Jin, Tiefeng
    Piao, Yingshi
    Liu, Chao
    Lin, Zhenhua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (06): : 3018 - 3027
  • [7] Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients
    He, Zi-Li
    Zheng, He
    Lin, Hui
    Miao, Xiong-Ying
    Zhong, De-Wu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (33) : 4177 - 4182
  • [8] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
    Zhu, Zebin
    Zhang, Yixi
    Huang, Chensong
    Tang, Yunhua
    Sun, Chengjun
    Ju, Weiqiang
    He, Xiaoshun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5559 - 5572
  • [9] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    Li, YueGuo
    Yu, Hai Peng
    Zhang, Peng
    HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 488 - 492
  • [10] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    YueGuo Li
    Hai Peng Yu
    Peng Zhang
    Hepatology International, 2016, 10 : 488 - 492